EG668339 Activators
Family with sequence similarity 236, member F activators are a diverse group of compounds that exert their functional effects through various intracellular signaling pathways, ultimately enhancing the activity of Fam236f. Forskolin, through its elevation of cAMP levels, amplifies PKA activity, which then can enhance Fam236f function through phosphorylation, potentially altering its conformation and activity. IBMX, by maintaining high cAMP levels, similarly promotes PKA-mediated enhancement of Fam236f activity. PMA, by activating PKC, and Okadaic Acid, by inhibiting phosphatases, both contribute to a phosphorylation landscape favorable for Fam236f activity enhancement.
Secondly, EGF activates the EGF receptor leading to MAPK/ERK pathway activation, which can upregulate Fam236f activity by promoting downstream signaling events that may influence Fam236f's functional state. Inhibitors like LY294002 and U0126, though initially act by dampening PI3K and MEK1/2 activities respectively, can lead to compensatory feedback mechanisms that ultimately enhance the activity of Fam236f. SB203580, by inhibiting p38 MAPK, and Rapamycin, through mTOR inhibition, can affect several signaling pathways and phosphorylation states, resulting in Fam236f activity enhancement indirectly.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Isobutylmethylxanthine (IBMX) is a non-selective inhibitor of phosphodiesterases, enzymes responsible for the breakdown of cAMP. By preventing cAMP degradation, IBMX can enhance the signaling pathways that rely on cAMP as a second messenger, potentially leading to an increase in Fam236f activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC), which is involved in a multitude of cellular processes. PKC activation can lead to downstream effects that include changes in the phosphorylation state of various proteins, possibly resulting in enhanced activity of Fam236f. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
This compound is an inhibitor of protein phosphatases PP1 and PP2A, leading to increased phosphorylation levels of cellular proteins. Inhibition of these phosphatases can indirectly result in the augmented activity of Fam236f due to reduced dephosphorylation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, which can result in the modulation of the AKT signaling pathway. By influencing this pathway, the compound can alter the phosphorylation status of downstream proteins, potentially enhancing the activity of Fam236f. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
This compound is a selective inhibitor of MEK1/2, which are upstream of ERK in the MAPK pathway. By modulating this pathway, U0126 can lead to the alteration of downstream protein activity, potentially enhancing Fam236f function. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a specific inhibitor of p38 MAPK, which is involved in response to stress stimuli. Modulating the p38 MAPK pathway may affect the activity of various proteins, potentially leading to an enhancement of Fam236f function. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, which is a central regulator of cell growth and proliferation. Through the inhibition of mTOR, Rapamycin can indirectly affect the phosphorylation status of downstream targets, potentially enhancing the activity of Fam236f. | ||||||
W-7 | 61714-27-0 | sc-201501 sc-201501A sc-201501B | 50 mg 100 mg 1 g | $166.00 $306.00 $1675.00 | 18 | |
W-7 is a calmodulin antagonist, affecting calcium signaling pathways. By altering calcium signaling, W-7 could potentially enhance Fam236f activity through calcium-dependent phosphorylation pathways. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
KN-93 is an inhibitor of Ca2+/calmodulin-dependent protein kinase II (CaMKII). Inhibition of CaMKII can modulate various cellular processes, potentially leading to an enhancement of Fam236f activity through altered phosphorylation patterns. | ||||||
NSC 23766 | 733767-34-5 | sc-204823 sc-204823A | 10 mg 50 mg | $151.00 $609.00 | 75 | |
This compound inhibits Rac1, part of the Rho family of GTPases. By modulating the activity of small GTPases, NSC 23766 can indirectly influence actin cytoskeletal arrangements, potentially enhancing the activity of Fam236f. | ||||||